Mount Sinai Researcher Receives Prestigious Award From the Asbestos Disease Awareness Organization
Andrea Wolf, MD, recognized for lifetime achievements in advancing understanding of mesothelioma
Andrea Wolf, MD, Director of the New York Mesothelioma Program at the Mount Sinai Health System, has received the prestigious 2022 Irving J. Selikoff Lifetime Achievement Award from the Asbestos Disease Awareness Organization.
The award is presented annually to an individual or organization for their dedication to increasing awareness and prevention efforts to eliminate asbestos-related diseases. The award is named in honor of Dr. Selikoff, who first discovered the relationship between asbestos and mesothelioma at Mount Sinai, establishing a legacy of expertise in this disease, occupational medicine, and environmental medicine.
Mesothelioma is a type of lung cancer, and those who are most at risk of developing mesothelioma are people who have had long-term exposure to asbestos, such as construction workers, pipefitters, and shipyard workers. It takes many years for mesothelioma to develop following exposure to asbestos.
“Dr. Wolf has been integral in the development of lung cancer screening and nodule follow-up programs for underserved patients at Mount Sinai,” said Raja M. Flores, MD, Chair of Thoracic Surgery, and the Steven and Anne Ames Professor in Thoracic Surgery, at the Icahn School of Medicine at Mount Sinai. “She has received accolades from patients and colleagues for helping to provide the highest level of care to minority and socioeconomically disadvantaged patients. Her skills, knowledge, and judgment, combined with a passion for her patients and their families, have gained her a reputation for unparalleled clinical excellence.”
An outstanding surgeon and clinician, Dr. Wolf focuses her research on malignant pleural mesothelioma, a rare tumor that involves the lining of the lungs and chest wall. Drawing on her expertise in statistical analysis, Dr. Wolf has conducted database studies to investigate outcomes, as well as racial and gender disparities, among patients with mesothelioma and other thoracic malignancies.
She has distinguished herself academically by authoring more than 70 peer-reviewed publications, 20 book chapters, and 25 abstracts, and delivering more than 45 presentations and invited talks. In 2020, Dr. Wolf and the New York Mesothelioma Program team received the International Association for the Study of Lung Cancer Care Team Award.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
Lung Cancer Death Decline Associated With Screening, Earlier Diagnosis, and Surgery
Dec 17, 2021 View All Press Releases